These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7643943)

  • 1. Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosa.
    Høiby N
    Neth J Med; 1995 Jun; 46(6):280-7. PubMed ID: 7643943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing epidemiology of Pseudomonas aeruginosa infection in Danish cystic fibrosis patients (1974-1995).
    Frederiksen B; Koch C; Høiby N
    Pediatr Pulmonol; 1999 Sep; 28(3):159-66. PubMed ID: 10495331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis.
    Frederiksen B; Koch C; Høiby N
    Pediatr Pulmonol; 1997 May; 23(5):330-5. PubMed ID: 9168506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
    Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
    J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
    J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication of early Pseudomonas aeruginosa infection.
    Høiby N; Frederiksen B; Pressler T
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():49-54. PubMed ID: 16023416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa and Burkholderia cepacia infection in cystic fibrosis patients treated in Toronto and Copenhagen.
    Johansen HK; Kovesi TA; Koch C; Corey M; Høiby N; Levison H
    Pediatr Pulmonol; 1998 Aug; 26(2):89-96. PubMed ID: 9727758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.
    Pedersen SS; Jensen T; Høiby N; Koch C; Flensborg EW
    Acta Paediatr Scand; 1987 Nov; 76(6):955-61. PubMed ID: 3425313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temocillin and cystic fibrosis: outcome of intravenous administration in patients infected with Pseudomonas cepacia.
    Taylor RF; Gaya H; Hodson ME
    J Antimicrob Chemother; 1992 Mar; 29(3):341-4. PubMed ID: 1375595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Pseudomonas cepacia colonization among patients with cystic fibrosis.
    John M; Ecclestone E; Hunter E; Couroux P; Hussain Z
    Pediatr Pulmonol; 1994 Aug; 18(2):108-13. PubMed ID: 7526323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre - results of a 10-year prospective study.
    Wiehlmann L; Cramer N; Ulrich J; Hedtfeld S; Weissbrodt H; Tümmler B
    Int J Med Microbiol; 2012 Mar; 302(2):69-77. PubMed ID: 22196973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment.
    Valerius NH; Koch C; Høiby N
    Lancet; 1991 Sep; 338(8769):725-6. PubMed ID: 1679870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.
    Lee TW; Brownlee KG; Denton M; Littlewood JM; Conway SP
    Pediatr Pulmonol; 2004 Feb; 37(2):104-10. PubMed ID: 14730654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G; Jansen S; Noll H; Grupp H; Frank F; Botzenhart K; Magdorf K; Wahn U
    Pediatr Pulmonol; 1996 Feb; 21(2):90-100. PubMed ID: 8882212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of inhaled tobramycin on early Pseudomonas aeruginosa colonisation in patients with cystic fibrosis.
    Ratjen F; Döring G; Nikolaizik WH
    Lancet; 2001 Sep; 358(9286):983-4. PubMed ID: 11583754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.